Liaoning Accounts Payable vs Non Current Liabilities Other Analysis
| 688739 Stock | 27.32 0.43 1.60% |
Liaoning Chengda financial indicator trend analysis is infinitely more than just investigating Liaoning Chengda Bio recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Liaoning Chengda Bio is a good investment. Please check the relationship between Liaoning Chengda Accounts Payable and its Non Current Liabilities Other accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Liaoning Chengda Biotechnology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
Accounts Payable vs Non Current Liabilities Other
Accounts Payable vs Non Current Liabilities Other Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Liaoning Chengda Bio Accounts Payable account and Non Current Liabilities Other. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between Liaoning Chengda's Accounts Payable and Non Current Liabilities Other is 0.56. Overlapping area represents the amount of variation of Accounts Payable that can explain the historical movement of Non Current Liabilities Other in the same time period over historical financial statements of Liaoning Chengda Biotechnology, assuming nothing else is changed. The correlation between historical values of Liaoning Chengda's Accounts Payable and Non Current Liabilities Other is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Accounts Payable of Liaoning Chengda Biotechnology are associated (or correlated) with its Non Current Liabilities Other. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Non Current Liabilities Other has no effect on the direction of Accounts Payable i.e., Liaoning Chengda's Accounts Payable and Non Current Liabilities Other go up and down completely randomly.
Correlation Coefficient | 0.56 |
| Relationship Direction | Positive |
| Relationship Strength | Weak |
Accounts Payable
An accounting item on the balance sheet that represents Liaoning Chengda obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Liaoning Chengda Bio are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.Non Current Liabilities Other
Most indicators from Liaoning Chengda's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Liaoning Chengda Bio current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Liaoning Chengda Biotechnology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. As of December 2, 2024, Tax Provision is expected to decline to about 102.7 M. In addition to that, Selling General Administrative is expected to decline to about 452.6 M
| 2021 | 2022 | 2023 | 2024 (projected) | Net Interest Income | 4.1M | 55.6M | 69.9M | 73.4M | Tax Provision | 138.5M | 124.1M | 110.5M | 102.7M |
Liaoning Chengda fundamental ratios Correlations
Click cells to compare fundamentals
Liaoning Chengda Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Currently Active Assets on Macroaxis
Other Information on Investing in Liaoning Stock
Balance Sheet is a snapshot of the financial position of Liaoning Chengda Bio at a specified time, usually calculated after every quarter, six months, or one year. Liaoning Chengda Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Liaoning Chengda and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Liaoning currently owns. An asset can also be divided into two categories, current and non-current.